SCHEMBL20747765

SCHEMBL20747765

CCCC(C)(C)COC(=O)C(C)(C)N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
HSD17B10 Q99714 2/20 0.46
TSHR P16473 3/20 0.35
CYP3A4 P08684 1/20 0.35
NFKB1 P19838 1/20 0.35
ADRA1A P35348 1/20 0.35
RAB9A P51151 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP4F2 P78329 2/20 0.34
CYP4A11 Q02928 2/20 0.34
ALOX15 P16050 1/20 0.33
FDPS P14324 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ELANE P08246 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747687 0.83 LMNA (0.35) LMNAHSD17B10ALOX15SERPINE1
SCHEMBL22475161 0.82 LMNA (0.41) LMNAHSD17B10TSHRCYP3A4NFKB1
SCHEMBL22417487 0.82 CYP4F2 (0.47) LMNAHSD17B10TSHRCYP3A4NFKB1
SCHEMBL14991491 0.79 ALDH1A1 (0.48) LMNAHSD17B10TSHRCYP3A4NFKB1
SCHEMBL1134032 0.78
SCHEMBL12060192 0.77 ALDH1A1 (0.50) LMNAHSD17B10TSHRCYP3A4NFKB1
SCHEMBL16940047 0.76 KMT2A (0.36) LMNAHSD17B10KMT2A
Hydrochloric Acid SCHEMBL1278919 0.76 ALOX15 (0.46) LMNAHSD17B10TSHRCYP3A4CYP4F2
SCHEMBL18481160 0.75
SCHEMBL16301006 0.75 THRB (0.38) LMNAHSD17B10ALOX15THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451847-B1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES IGM GROUP B V (NL) 2021-11-24 EP disclosed
US-10208045-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208045-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK LMNA 2972/4885HSD17B10 3567/4885TSHR 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.